PLX logo

Protalix BioTherapeutics (PLX) Non Current Assets

Annual Non Current Assets

$14.50 M
+$3.60 M+32.96%

December 31, 2023


Summary


Performance

PLX Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPLXbalance sheetmetrics:

Quarterly Non Current Assets

$13.71 M
-$463.00 K-3.27%

September 30, 2024


Summary


Performance

PLX Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPLXbalance sheetmetrics:

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

PLX Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+33.0%-8.3%
3 y3 years+18.8%-8.3%
5 y5 years+78.0%-8.3%

PLX Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+33.0%-8.3%+25.7%
5 y5-yearat high+33.0%-45.4%+25.7%
alltimeall time-24.9%-100.0%-45.4%-100.0%

Protalix BioTherapeutics Non Current Assets History

DateAnnualQuarterly
Sep 2024
-
$13.71 M(-3.3%)
Jun 2024
-
$14.17 M(-1.7%)
Mar 2024
-
$14.42 M(-0.6%)
Dec 2023
$69.93 M(+55.8%)
$14.50 M(-3.0%)
Sep 2023
-
$14.95 M(+0.7%)
Jun 2023
-
$14.84 M(+33.0%)
Mar 2023
-
$11.16 M(+2.3%)
Dec 2022
$44.88 M(-27.2%)
$10.91 M(-0.4%)
Sep 2022
-
$10.95 M(+0.1%)
Jun 2022
-
$10.94 M(-7.7%)
Mar 2022
-
$11.85 M(-1.3%)
Dec 2021
$61.67 M(+10.7%)
$12.00 M(-2.1%)
Sep 2021
-
$12.26 M(-0.2%)
Jun 2021
-
$12.28 M(+1.5%)
Mar 2021
-
$12.09 M(-1.0%)
Dec 2020
$55.72 M(+71.6%)
$12.21 M(+1.9%)
Sep 2020
-
$11.98 M(-31.6%)
Jun 2020
-
$17.50 M(-30.3%)
Mar 2020
-
$25.11 M(+94.4%)
Dec 2019
$32.48 M(-38.7%)
$12.91 M(-2.8%)
Sep 2019
-
$13.29 M(-2.6%)
Jun 2019
-
$13.64 M(-0.4%)
Mar 2019
-
$13.70 M(+68.2%)
Dec 2018
$52.98 M(-15.4%)
$8.15 M(-17.3%)
Sep 2018
-
$9.86 M(+13.7%)
Jun 2018
-
$8.67 M(-4.8%)
Mar 2018
-
$9.11 M(-4.7%)
Dec 2017
$62.65 M(-12.8%)
$9.56 M(-3.5%)
Sep 2017
-
$9.90 M(-2.0%)
Jun 2017
-
$10.11 M(-1.9%)
Mar 2017
-
$10.31 M(-0.7%)
Dec 2016
$71.87 M(-16.3%)
$10.38 M(-4.1%)
Sep 2016
-
$10.83 M(-3.5%)
Jun 2016
-
$11.22 M(+1.6%)
Mar 2016
-
$11.04 M(-2.9%)
Dec 2015
$85.88 M(+31.1%)
$11.37 M(-2.1%)
Sep 2015
-
$11.62 M(-3.9%)
Jun 2015
-
$12.09 M(-3.0%)
Mar 2015
-
$12.46 M(-2.9%)
Dec 2014
$65.52 M(-33.1%)
$12.84 M(-5.5%)
Sep 2014
-
$13.59 M(-4.9%)
Jun 2014
-
$14.29 M(-3.8%)
Mar 2014
-
$14.86 M(-3.7%)
Dec 2013
$97.90 M(+60.1%)
$15.43 M(-3.3%)
Sep 2013
-
$15.96 M(-2.6%)
Jun 2013
-
$16.37 M(-4.0%)
Mar 2013
-
$17.05 M(-2.9%)
Dec 2012
$61.17 M(+88.3%)
$17.56 M(-1.4%)
Sep 2012
-
$17.80 M(-3.3%)
Jun 2012
-
$18.41 M(-1.1%)
Mar 2012
-
$18.63 M(-3.6%)
Dec 2011
$32.49 M
$19.31 M(-6.0%)
Sep 2011
-
$20.55 M(-0.7%)
DateAnnualQuarterly
Jun 2011
-
$20.69 M(+10.8%)
Mar 2011
-
$18.67 M(+1.5%)
Dec 2010
$46.33 M(-44.5%)
$18.40 M(+10.1%)
Sep 2010
-
$16.71 M(+7.8%)
Jun 2010
-
$15.50 M(+0.3%)
Mar 2010
-
$15.45 M(+1.3%)
Dec 2009
$83.41 M(+92.2%)
$15.26 M(+19.0%)
Sep 2009
-
$12.83 M(+15.5%)
Jun 2009
-
$11.11 M(+24.3%)
Mar 2009
-
$8.94 M(+20.4%)
Dec 2008
$43.39 M(-31.3%)
$7.42 M(+7.1%)
Sep 2008
-
$6.93 M(+6.0%)
Jun 2008
-
$6.54 M(+10.0%)
Mar 2008
-
$5.95 M(+19.7%)
Dec 2007
$63.17 M(+160.0%)
$4.97 M(+19.3%)
Sep 2007
-
$4.17 M(+15.9%)
Jun 2007
-
$3.59 M(+11.7%)
Mar 2007
-
$3.22 M(+19.3%)
Dec 2006
$24.29 M(+386.3%)
$2.70 M(>+9900.0%)
Sep 2006
-
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
Mar 2006
-
$0.00(-100.0%)
Dec 2005
$5.00 M(+782.5%)
$2.23 M(>+9900.0%)
Sep 2005
-
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
Mar 2005
-
$0.00(0.0%)
Dec 2004
$566.00 K(-22.9%)
$0.00(0.0%)
Sep 2004
-
$0.00(0.0%)
Jun 2004
-
$0.00(0.0%)
Mar 2004
-
$0.00(0.0%)
Dec 2003
$734.30 K(-11.7%)
$0.00(0.0%)
Sep 2003
-
$0.00(0.0%)
Jun 2003
-
$0.00(0.0%)
Mar 2003
-
$0.00(-100.0%)
Dec 2002
$832.00 K(-13.0%)
$43.30 K(-12.3%)
Sep 2002
-
$49.40 K(-10.7%)
Jun 2002
-
$55.30 K(-9.6%)
Mar 2002
-
$61.20 K(-8.8%)
Dec 2001
$956.10 K(-46.9%)
$67.10 K(-55.0%)
Sep 2001
-
$149.20 K(+84.0%)
Jun 2001
-
$81.10 K(-6.1%)
Mar 2001
-
$86.40 K(-17.9%)
Dec 2000
$1.80 M(+9.4%)
$105.30 K(-12.0%)
Sep 2000
-
$119.70 K(-51.1%)
Jun 2000
-
$244.70 K(-30.3%)
Mar 2000
-
$351.20 K(-13.1%)
Dec 1999
$1.64 M(-36.4%)
$404.30 K(-45.0%)
Sep 1999
-
$735.30 K(-24.7%)
Jun 1999
-
$976.00 K(-50.9%)
Mar 1999
-
$1.99 M
Dec 1998
$2.59 M(-65.2%)
-
Dec 1997
$7.43 M(+1.3%)
-
Dec 1996
$7.33 M
-

FAQ

  • What is Protalix BioTherapeutics annual long term assets?
  • What is the all time high annual non current assets for Protalix BioTherapeutics?
  • What is Protalix BioTherapeutics annual non current assets year-on-year change?
  • What is Protalix BioTherapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Protalix BioTherapeutics?
  • What is Protalix BioTherapeutics quarterly non current assets year-on-year change?

What is Protalix BioTherapeutics annual long term assets?

The current annual non current assets of PLX is $14.50 M

What is the all time high annual non current assets for Protalix BioTherapeutics?

Protalix BioTherapeutics all-time high annual long term assets is $19.31 M

What is Protalix BioTherapeutics annual non current assets year-on-year change?

Over the past year, PLX annual long term assets has changed by +$3.60 M (+32.96%)

What is Protalix BioTherapeutics quarterly long term assets?

The current quarterly non current assets of PLX is $13.71 M

What is the all time high quarterly non current assets for Protalix BioTherapeutics?

Protalix BioTherapeutics all-time high quarterly long term assets is $25.11 M

What is Protalix BioTherapeutics quarterly non current assets year-on-year change?

Over the past year, PLX quarterly long term assets has changed by -$1.24 M (-8.30%)